José Luis Dapena Selected Research

Drug Therapy (Chemotherapy)

1/2022

Venous thromboembolism in pediatric patients with acute lymphoblastic leukemia under chemotherapy treatment. Risk factors and usefulness of thromboprophylaxis. Results of LAL-SEHOP-PETHEMA-2013.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

José Luis Dapena Research Topics

Disease

4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 01/2017
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 08/2019 - 09/2018
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Venous Thromboembolism 01/2022
1	Thrombophilia 01/2022
1	Down Syndrome (Down's Syndrome) 01/2019
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 01/2011
1	Juvenile Myelomonocytic Leukemia 01/2011
1	Noonan Syndrome (Female Pseudo-Turner Syndrome) 01/2011

Drug/Important Bio-Agent (IBA)

2	Inosine Triphosphate (ITP)IBA 08/2019 - 09/2018
1	AnticoagulantsIBA 01/2022
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022
1	Inotuzumab OzogamicinIBA 01/2019
1	Asparaginase (Elspar)FDA Link 01/2017

Therapy/Procedure

2	Hematopoietic Stem Cell Transplantation 01/2023 - 01/2011
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2023
1	Stem Cell Transplantation 01/2023
1	Drug Therapy (Chemotherapy) 01/2022
1	Therapeutics 01/2022